Because uAGT levels precede the onset of albuminuria—a primary indicator of RAS activation—in normotensive patients with type 2 DM (T2DM), it has been suggested that uAGT may potentially serve as an early marker of intrarenal RAS activation and progressive CKD in T2DM patients without hypertension. Here, DPAGT1 is linked to chronic kidney disease.